270 related articles for article (PubMed ID: 22846048)
1. Patient and parent preferences for immunoglobulin treatments: a conjoint analysis.
Mohamed AF; Kilambi V; Luo MP; Iyer RG; Li-McLeod JM
J Med Econ; 2012; 15(6):1183-91. PubMed ID: 22846048
[TBL] [Abstract][Full Text] [Related]
2. Patient and parent preferences for haemophilia A treatments.
Mohamed AF; Epstein JD; Li-McLeod JM
Haemophilia; 2011 Mar; 17(2):209-14. PubMed ID: 21070493
[TBL] [Abstract][Full Text] [Related]
3. Patients rank toxicity against progression free survival in second-line treatment of advanced renal cell carcinoma.
Wong MK; Mohamed AF; Hauber AB; Yang JC; Liu Z; Rogerio J; Garay CA
J Med Econ; 2012; 15(6):1139-48. PubMed ID: 22808923
[TBL] [Abstract][Full Text] [Related]
4. A survey of children's preferences for influenza vaccine attributes.
Flood EM; Ryan KJ; Rousculp MD; Beusterien KM; Block SL; Hall MC; Mahadevia PJ
Vaccine; 2011 Jun; 29(26):4334-40. PubMed ID: 21510993
[TBL] [Abstract][Full Text] [Related]
5. Patients' willingness to trade off between the duration and frequency of rheumatoid arthritis treatments.
Poulos C; Hauber AB; González JM; Turpcu A
Arthritis Care Res (Hoboken); 2014 Jul; 66(7):1008-15. PubMed ID: 24339373
[TBL] [Abstract][Full Text] [Related]
6. Patient Preferences for Preventive Migraine Treatments: A Discrete-Choice Experiment.
Mansfield C; Gebben DJ; Sutphin J; Tepper SJ; Schwedt TJ; Sapra S; Shah N
Headache; 2019 May; 59(5):715-726. PubMed ID: 30861110
[TBL] [Abstract][Full Text] [Related]
7. Patients' preferences for treatment outcomes for advanced non-small cell lung cancer: a conjoint analysis.
Bridges JF; Mohamed AF; Finnern HW; Woehl A; Hauber AB
Lung Cancer; 2012 Jul; 77(1):224-31. PubMed ID: 22369719
[TBL] [Abstract][Full Text] [Related]
8. Avoidance of weight gain is important for oral type 2 diabetes treatments in Sweden and Germany: patient preferences.
Mohamed AF; Zhang J; Johnson FR; Lomon ID; Malvolti E; Townsend R; Ostgren CJ; Parhofer KG
Diabetes Metab; 2013 Oct; 39(5):397-403. PubMed ID: 23880594
[TBL] [Abstract][Full Text] [Related]
9. Physicians' preferences for bone metastases drug therapy in the United States.
Arellano J; Hauber AB; Mohamed AF; Gonzalez JM; Collins H; Hechmati G; Gatta F; Qian Y
Value Health; 2015 Jan; 18(1):78-83. PubMed ID: 25595237
[TBL] [Abstract][Full Text] [Related]
10. Patient Preferences for Injectable Treatments for Multiple Sclerosis in the United States: A Discrete-Choice Experiment.
Poulos C; Kinter E; Yang JC; Bridges JF; Posner J; Reder AT
Patient; 2016 Apr; 9(2):171-80. PubMed ID: 26259849
[TBL] [Abstract][Full Text] [Related]
11. Patient, Caregiver, and Nurse Preferences for Treatments for Bone Metastases from Solid Tumors.
Qian Y; Arellano J; Hauber AB; Mohamed AF; Gonzalez JM; Hechmati G; Gatta F; Harrelson S; Campbell-Baird C
Patient; 2016 Aug; 9(4):323-33. PubMed ID: 26821359
[TBL] [Abstract][Full Text] [Related]
12. Physicians' stated trade-off preferences for chronic hepatitis B treatment outcomes in Germany, France, Spain, Turkey, and Italy.
Mohamed AF; Johnson FR; Hauber AB; Lescrauwaet B; Masterson A
Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):419-26. PubMed ID: 22330238
[TBL] [Abstract][Full Text] [Related]
13. Patient preferences for biologic agents in rheumatoid arthritis: a discrete-choice experiment.
Augustovski F; Beratarrechea A; Irazola V; Rubinstein F; Tesolin P; Gonzalez J; Lencina V; Scolnik M; Waimann C; Navarta D; Citera G; Soriano ER
Value Health; 2013; 16(2):385-93. PubMed ID: 23538191
[TBL] [Abstract][Full Text] [Related]
14. Parents' preferences for drug treatments in juvenile idiopathic arthritis: a discrete choice experiment.
Burnett HF; Regier DA; Feldman BM; Miller FA; Ungar WJ
Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1382-91. PubMed ID: 22504893
[TBL] [Abstract][Full Text] [Related]
15. Assessment of parents' preferences for the treatment of school-age children with ADHD: a discrete choice experiment.
Fegert JM; Slawik L; Wermelskirchen D; Nübling M; Mühlbacher A
Expert Rev Pharmacoecon Outcomes Res; 2011 Jun; 11(3):245-52. PubMed ID: 21671692
[TBL] [Abstract][Full Text] [Related]
16. Parent preferences for pediatric influenza vaccine attributes.
Flood EM; Ryan KJ; Rousculp MD; Beusterien KM; Divino VM; Block SL; Hall MC; Mahadevia PJ
Clin Pediatr (Phila); 2011 Apr; 50(4):338-47. PubMed ID: 21196417
[TBL] [Abstract][Full Text] [Related]
17. Comparing the Relative Importance of Attributes of Metastatic Renal Cell Carcinoma Treatments to Patients and Physicians in the United States: A Discrete-Choice Experiment.
González JM; Doan J; Gebben DJ; Boeri M; Fishman M
Pharmacoeconomics; 2018 Aug; 36(8):973-986. PubMed ID: 29869777
[TBL] [Abstract][Full Text] [Related]
18. Preferences and Stated Adherence for Antibiotic Treatment of Cystic Fibrosis Pseudomonas Infections.
Mohamed AF; Johnson FR; Balp MM; Calado F
Patient; 2016 Feb; 9(1):59-67. PubMed ID: 25838082
[TBL] [Abstract][Full Text] [Related]
19. Patient preference for latent tuberculosis infection preventive treatment: a discrete choice experiment.
Guo N; Marra CA; FitzGerald JM; Elwood RK; Anis AH; Marra F
Value Health; 2011; 14(6):937-43. PubMed ID: 21914516
[TBL] [Abstract][Full Text] [Related]
20. PREFERENCES OF PATIENTS WITH MULTIPLE SCLEROSIS FOR ATTRIBUTES OF INJECTABLE MULTIPLE SCLEROSIS TREATMENTS IN THE UNITED KINGDOM AND FRANCE.
Poulos C; Kinter E; van Beek J; Christensen K; Posner J
Int J Technol Assess Health Care; 2018 Jan; 34(4):425-433. PubMed ID: 30251947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
